Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae

Diagnostic Microbiology and Infectious Disease

Volumn 39, Issue 3, 2001, Pages 181-185

  Stein, G E ^a   Schooley, S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ADULT; AZITHROMYCIN; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE;

EID: 0035043570     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00239-X     Document Type: Article

References (25)

1. Pneumococcal macrolide resistance - Myth or reality
2. Community-acquired pneumonia in adults: Guidelines for management
3. Pharmacodynamics of macrolides, azalides, and streptogramins: Effect on extracellular pathogens
4. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States
5. Pharmacokinetic/Pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
6. Antimicrobial combinations
7. Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance
8. Comparison of antibiotic activities by using serum bactericidal activity over time
9. Comparative in vitro Activities of New 14-, 15-, and 16-membered Macrolides
10. Management of community-acquired. Pneumonia in the era of pneumococcal resistance
11. Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxy clarithromycin
12. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
13. The pharmacokinetics of azithromycin and their clinical significance
14. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin
15. Clarithromycin in the management of community-acquired pneumonia
16. In-vitro concentration of azithromycin in human phagocytic cells
17. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin
18. Pneumonia in the elderly patient
19. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in the United States, 1997-1998
20. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study
21. Use of clindamycin disks to detect macrolide resistance. Mediated by erm B and mef E in Streptococcus pneumoniae isolates from adults and children
22. Azithromycin and clarithromycin: Overview and comparison with erythromycin
23. Serum bactericidal activity as a monitor of antibiotic therapy